116 related articles for article (PubMed ID: 35119675)
1. Molecular Design, Synthesis, and Evaluation of SNIPER (ER) that Induces Targeted Protein Degradation of ERα.
Ohoka N; Yokoo H; Okuhira K; Demizu Y; Naito M
Methods Mol Biol; 2022; 2418():363-382. PubMed ID: 35119675
[TBL] [Abstract][Full Text] [Related]
2. Molecular Design, Synthesis, and Evaluation of SNIPER(ER) That Induces Proteasomal Degradation of ERα.
Okuhira K; Demizu Y; Hattori T; Ohoka N; Shibata N; Kurihara M; Naito M
Methods Mol Biol; 2016; 1366():549-560. PubMed ID: 26585163
[TBL] [Abstract][Full Text] [Related]
3. Development of hybrid small molecules that induce degradation of estrogen receptor-alpha and necrotic cell death in breast cancer cells.
Okuhira K; Demizu Y; Hattori T; Ohoka N; Shibata N; Nishimaki-Mogami T; Okuda H; Kurihara M; Naito M
Cancer Sci; 2013 Nov; 104(11):1492-8. PubMed ID: 23992566
[TBL] [Abstract][Full Text] [Related]
4.
Ohoka N; Okuhira K; Ito M; Nagai K; Shibata N; Hattori T; Ujikawa O; Shimokawa K; Sano O; Koyama R; Fujita H; Teratani M; Matsumoto H; Imaeda Y; Nara H; Cho N; Naito M
J Biol Chem; 2017 Mar; 292(11):4556-4570. PubMed ID: 28154167
[TBL] [Abstract][Full Text] [Related]
5. Derivatization of inhibitor of apoptosis protein (IAP) ligands yields improved inducers of estrogen receptor α degradation.
Ohoka N; Morita Y; Nagai K; Shimokawa K; Ujikawa O; Fujimori I; Ito M; Hayase Y; Okuhira K; Shibata N; Hattori T; Sameshima T; Sano O; Koyama R; Imaeda Y; Nara H; Cho N; Naito M
J Biol Chem; 2018 May; 293(18):6776-6790. PubMed ID: 29545311
[TBL] [Abstract][Full Text] [Related]
6. The GPER1/SPOP axis mediates ubiquitination-dependent degradation of ERα to inhibit the growth of breast cancer induced by oestrogen.
Zhang N; Sun P; Xu Y; Li H; Liu H; Wang L; Cao Y; Zhou K; TinghuaiWang
Cancer Lett; 2021 Feb; 498():54-69. PubMed ID: 33069770
[TBL] [Abstract][Full Text] [Related]
7. CHIP (carboxyl terminus of Hsc70-interacting protein) promotes basal and geldanamycin-induced degradation of estrogen receptor-alpha.
Fan M; Park A; Nephew KP
Mol Endocrinol; 2005 Dec; 19(12):2901-14. PubMed ID: 16037132
[TBL] [Abstract][Full Text] [Related]
8. Ligand-dependent switching of ubiquitin-proteasome pathways for estrogen receptor.
Tateishi Y; Kawabe Y; Chiba T; Murata S; Ichikawa K; Murayama A; Tanaka K; Baba T; Kato S; Yanagisawa J
EMBO J; 2004 Dec; 23(24):4813-23. PubMed ID: 15538384
[TBL] [Abstract][Full Text] [Related]
9. Clomiphene citrate down-regulates estrogen receptor-α through the ubiquitin-proteasome pathway in a human endometrial cancer cell line.
Amita M; Takahashi T; Igarashi H; Nagase S
Mol Cell Endocrinol; 2016 Jun; 428():142-7. PubMed ID: 27033325
[TBL] [Abstract][Full Text] [Related]
10. Targeted Degradation of Proteins Localized in Subcellular Compartments by Hybrid Small Molecules.
Okuhira K; Shoda T; Omura R; Ohoka N; Hattori T; Shibata N; Demizu Y; Sugihara R; Ichino A; Kawahara H; Itoh Y; Ishikawa M; Hashimoto Y; Kurihara M; Itoh S; Saito H; Naito M
Mol Pharmacol; 2017 Mar; 91(3):159-166. PubMed ID: 27965304
[TBL] [Abstract][Full Text] [Related]
11. Cancer cell death induced by novel small molecules degrading the TACC3 protein via the ubiquitin-proteasome pathway.
Ohoka N; Nagai K; Hattori T; Okuhira K; Shibata N; Cho N; Naito M
Cell Death Dis; 2014 Nov; 5(11):e1513. PubMed ID: 25375378
[TBL] [Abstract][Full Text] [Related]
12. REGγ regulates ERα degradation via ubiquitin-proteasome pathway in breast cancer.
Chai F; Liang Y; Bi J; Chen L; Zhang F; Cui Y; Jiang J
Biochem Biophys Res Commun; 2015 Jan; 456(1):534-40. PubMed ID: 25490392
[TBL] [Abstract][Full Text] [Related]
13. Endometrial cancer-associated mutants of SPOP are defective in regulating estrogen receptor-α protein turnover.
Zhang P; Gao K; Jin X; Ma J; Peng J; Wumaier R; Tang Y; Zhang Y; An J; Yan Q; Dong Y; Huang H; Yu L; Wang C
Cell Death Dis; 2015 Mar; 6(3):e1687. PubMed ID: 25766326
[TBL] [Abstract][Full Text] [Related]
14. Apigenin manipulates the ubiquitin-proteasome system to rescue estrogen receptor-β from degradation and induce apoptosis in prostate cancer cells.
Singh V; Sharma V; Verma V; Pandey D; Yadav SK; Maikhuri JP; Gupta G
Eur J Nutr; 2015 Dec; 54(8):1255-67. PubMed ID: 25408199
[TBL] [Abstract][Full Text] [Related]
15. Targeted degradation of activating estrogen receptor α ligand-binding domain mutations in human breast cancer.
Gonzalez TL; Hancock M; Sun S; Gersch CL; Larios JM; David W; Hu J; Hayes DF; Wang S; Rae JM
Breast Cancer Res Treat; 2020 Apr; 180(3):611-622. PubMed ID: 32067153
[TBL] [Abstract][Full Text] [Related]
16. Intrinsic ubiquitin E3 ligase activity of histone acetyltransferase Hbo1 for estrogen receptor α.
Iizuka M; Susa T; Tamamori-Adachi M; Okinaga H; Okazaki T
Proc Jpn Acad Ser B Phys Biol Sci; 2017; 93(7):498-510. PubMed ID: 28769019
[TBL] [Abstract][Full Text] [Related]
17. Calcineurin regulates the stability and activity of estrogen receptor α.
Masaki T; Habara M; Sato Y; Goshima T; Maeda K; Hanaki S; Shimada M
Proc Natl Acad Sci U S A; 2021 Nov; 118(44):. PubMed ID: 34711683
[TBL] [Abstract][Full Text] [Related]
18. Bergapten induces ER depletion in breast cancer cells through SMAD4-mediated ubiquitination.
Panno ML; Giordano F; Rizza P; Pellegrino M; Zito D; Giordano C; Mauro L; Catalano S; Aquila S; Sisci D; De Amicis F; Vivacqua A; Fuqua SW; Andò S
Breast Cancer Res Treat; 2012 Nov; 136(2):443-55. PubMed ID: 23053665
[TBL] [Abstract][Full Text] [Related]
19. Phosphorylation of activation function-1 regulates proteasome-dependent nuclear mobility and E6-associated protein ubiquitin ligase recruitment to the estrogen receptor beta.
Picard N; Charbonneau C; Sanchez M; Licznar A; Busson M; Lazennec G; Tremblay A
Mol Endocrinol; 2008 Feb; 22(2):317-30. PubMed ID: 17962381
[TBL] [Abstract][Full Text] [Related]
20. Janus kinase 2--a novel negative regulator of estrogen receptor α function.
Gupta N; Grebhardt S; Mayer D
Cell Signal; 2012 Jan; 24(1):151-61. PubMed ID: 21907792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
